↓ Skip to main content

Irinotecan plus S‐1 versus S‐1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open‐labeled phase 3 trial

Overview of attention for article published in Cancer Communications, April 2019
Altmetric Badge

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Irinotecan plus S‐1 versus S‐1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open‐labeled phase 3 trial
Published in
Cancer Communications, April 2019
DOI 10.1186/s40880-019-0359-7
Pubmed ID
Authors

Jing Huang, Binghe Xu, Ying Liu, Junxing Huang, Ping Lu, Yi Ba, Lin Wu, Yuxian Bai, Shu Zhang, Jifeng Feng, Ying Cheng, Jie Li, Lu Wen, Xianglin Yuan, Changwu Ma, Chunhong Hu, Qingxia Fan, Xi Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 11%
Student > Ph. D. Student 3 7%
Researcher 3 7%
Other 2 5%
Professor > Associate Professor 2 5%
Other 7 16%
Unknown 22 50%
Readers by discipline Count As %
Medicine and Dentistry 10 23%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Biochemistry, Genetics and Molecular Biology 3 7%
Nursing and Health Professions 3 7%
Unspecified 1 2%
Other 3 7%
Unknown 21 48%